Form 4 for ICE Intercontinental Exchange
Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-18 · accession 0000950170-25-024505 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-02-20 | 2025-02-20 | ICE | Martin Lynn C | Pres, NYSE Group | G - Gift | $0.00 | -152 | 59.5K | -0.3% | $0 |
| DMT | 2025-02-20 | 2025-02-20 | ICE | Martin Lynn C | Pres, NYSE Group | S - Sale+OE | $166.63 | -10.5K | 63.6K | -14% | -$1.75M |
| DT | 2025-02-20 | 2025-02-20 | ICE | Martin Lynn C | Pres, NYSE Group | M - OptEx | $57.31 | +3,183 | 70.1K | +5% | +$182.4K |
| DT | 2025-02-20 | 2025-02-18 | ICE | Martin Lynn C | Pres, NYSE Group | A - Grant | $0.00 | +9,348 | 68.5K | +16% | $0 |
| DT | 2025-02-20 | 2025-02-18 | ICE | Martin Lynn C | Pres, NYSE Group | F - Tax | $166.71 | -1,591 | 66.9K | -2% | -$265.2K |
| DT | 2025-02-20 | 2025-02-20 | ICE | Martin Lynn C | Pres, NYSE Group | M - OptEx | $0.00 | -3,183 | 15.9K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-20 | G | D | 152 | $0.00 | 59,489 | D | — | — | (F6) This transaction involved a gift of 152 shares of the issuer's common stock by the reporting person to a philanthropic organization. (F9) The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period. (F8) The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year EBITDA PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting. (F7) The common stock number referred in Table I is an aggregate number and represents 42,154 shares of common stock, 5,834 unvested restricted stock units ("RSUs"), and 11,501 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year. |
| 2 | Common | Common Stock | 2025-02-20 | S | D | 3,963 | $167.02 | 59,641 | D | — | — | (F3) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of August 12, 2024. (F5) The price range for the aggregate amount sold by the direct holder is $166.86 - $167.28. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2025-02-20 | S | D | 6,518 | $166.39 | 63,604 | D | — | — | (F3) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of August 12, 2024. (F4) The price range for the aggregate amount sold by the direct holder is $165.86 - $166.85. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2025-02-20 | M | A | 3,183 | $57.31 | 70,122 | D | — | — | (F3) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of August 12, 2024. |
| 5 | Common | Common Stock | 2025-02-18 | A | A | 9,348 | $0.00 | 68,530 | D | — | — | (F1) Represents shares of performance based restricted stock units granted to the filing person on February 12, 2024. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2024 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 15, 2025, 1/3 on February 15, 2026 and 1/3 on February 15, 2027). Of the 9,348 shares, 3,116 were issued on February 18, 2025, of which 1,591 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 6,232 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. |
| 6 | Common | Common Stock | 2025-02-18 | F | D | 1,591 | $166.71 | 66,939 | D | — | — | (F2) Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. |
| 7 | Derivative | Employee Stock Option (right to buy) Holding | 2025-02-20 | M | D | 3,183 | $0.00 | 15,882 | D | $57.31 · — to 2027-01-18 | 3,183 Common Stock | (F10) These options are fully vested. |